• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,569.39 827.57
( 1.08%)
Global Indices
Nasdaq
52,658.24 149.83
(0.29%)
Dow Jones
7,594.79 30.15
(0.40%)
Hang Seng
68,634.11 890.26
(1.31%)
Nikkei 225
10,498.02 25.57
(0.24%)
Forex
USD-INR
95.45 -0.01
(-0.01%)
EUR-INR
109.10 0.17
(0.15%)
GBP-INR
127.94 0.35
(0.28%)
JPY-INR
0.59 0.00
(0.03%)

EQUITY - MARKET SCREENER

Indo National Ltd
Industry :  Dry Cells
BSE Code
ISIN Demat
Book Value()
504058
INE567A01028
282.8
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NIPPOBATRY
0
252.79
EPS(TTM)
Face Value()
Div & Yield %
0
5
1.11
 

Bacil Pharma standalone net profit rises 3000.00% in the March 2026 quarter
May 23,2026
Net profit of Bacil Pharma rose 3000.00% to Rs 0.62 crore in the quarter ended March 2026 as against Rs 0.02 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.

For the full year,net profit rose 290.00% to Rs 1.56 crore in the year ended March 2026 as against Rs 0.40 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 and during the previous year ended March 2025.